| Sterling Biotech has reported a standalone total income from operations of Rs 87.48 crore and a net loss of Rs 103.82 crore for the quarter ended Dec '15. Other income for the quarter was Rs 1.17 crore. | | For the quarter ended Dec 2014 the standalone total income from operations was Rs 122.38 crore and net loss was Rs 127.38 crore, and other income Rs 0.75 crore. | | Sterling Bio shares closed at 4.85 on February 12, 2016 (NSE) and has given -19.17% returns over the last 6 months and -19.17% over the last 12 months. |
|
| | Sterling Biotech | | Standalone Quarterly Results | -------- in Rs. Cr. -------- |
|
| Dec '15 | Sep '15 | | | Dec '14 | | Net Sales/Income from operations | 86.31 | 107.03 | | | 121.63 | | Other Operating Income | 1.17 | 0.99 | | | 0.75 | | Total Income From Operations | 87.48 | 108.02 | | | 122.38 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 65.79 | 63.59 | | | 87.97 | | Purchase of Traded Goods | -- | -- | | | -- | | Increase/Decrease in Stocks | -5.73 | 9.24 | | | 0.47 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 13.60 | 13.01 | | | 12.17 | | Depreciation | 70.22 | 70.21 | | | 84.80 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 8.08 | 7.32 | | | 9.32 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -64.48 | -55.34 | | | -72.35 | | Other Income | -- | -- | | | -- | | P/L Before Int., Excpt. Items & Tax | -64.48 | -55.34 | | | -72.35 | | Interest | 89.20 | 84.12 | | | 87.60 | | P/L Before Exceptional Items & Tax | -153.68 | -139.46 | | | -159.95 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | -153.68 | -139.46 | | | -159.95 | | Tax | -49.86 | -45.25 | | | -51.89 | | P/L After Tax from Ordinary Activities | -103.82 | -94.21 | | | -108.06 | | Prior Year Adjustments | -- | -- | | | -19.32 | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | -103.82 | -94.21 | | | -127.38 | | Equity Share Capital | 27.20 | 27.20 | | | 27.20 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | -3.82 | -3.46 | | | -3.97 | | Diluted EPS | -2.40 | -2.18 | | | -2.50 | | EPS After Extra Ordinary | | | | | | | Basic EPS | -3.82 | -3.46 | | | -3.97 | | Diluted EPS | -2.40 | -2.18 | | | -2.50 | | Public Share Holding | | | | | | | No Of Shares (Crores) | -- | 13.55 | | | 13.55 | | Share Holding (%) | -- | 49.82 | | | 49.82 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | -- | 5.08 | | | 5.08 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | 55.94 | | | 55.94 | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | 18.68 | | | 18.68 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | -- | 4.00 | | | 4.00 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | 44.06 | | | 44.06 | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | 14.71 | | | 14.71 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
